• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Martindale Pharma expands in Saudi Arabia

Martindale Pharma expands in Saudi Arabia

September 30, 2015
CenterWatch Staff

Martindale Pharma, a U.K.-based international specialty pharmaceutical company, has opened a scientific office in the Kingdom of Saudi Arabia (KSA) and has appointed Dr. Fahad Al Showaier as scientific office manager. He brings extensive international experience, having previously held a number of senior positions with Saudi companies including Jamjoom Pharma.

The opening of the scientific office in KSA forms part of Martindale Pharma’s strategy to commercialize its portfolio in defined international markets with high growth potential and is a key step to support growing the sales base. The office will be responsible for obtaining marketing authorization approvals of Martindale Pharma’s products with the Saudi Federal Drug Agency (SFDA). Martindale Pharma is planning in excess of 20 products to be approved in the next three years. The first marketing authorization was granted in September. The scientific office also will be responsible for providing accurate product information to physicians.

Saudi Arabia is a strategically important market with a population of 29 million growing at 3.3% annually. The total Saudi healthcare market is estimated at $28 billion (2014), with pharmaceutical product purchases accounting for $4.7 billion per annum.

Martindale Pharma employs more than 300 people, including a commercial team of more than 50 people operating in the U.K., Europe, Middle East, Australasia and Africa.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing